Merck & Co.

• Introduction
• Chapter 1 The Merck Legacy: Origins in Germany
• Chapter 2 Transplanting Roots: Merck Comes to America
• Chapter 3 War and Separation: From Subsidiary to Independence
• Chapter 4 The Early American Years: 1919–1929
• Chapter 5 Building on Science: The Rise of the Merck Research Laboratory
• Chapter 6 Mergers, Manuals, and Growth in the 1920s and 1930s
• Chapter 7 Breakthroughs in Medicine: Cortisone, Streptomycin, and Penicillin
• Chapter 8 Postwar Expansion and Innovation
• Chapter 9 The Sharp & Dohme Merger: Creating a Global Powerhouse
• Chapter 10 A Revolution in Vaccines: Hilleman and Lifesaving Discoveries
• Chapter 11 Developing New Drugs: From Statins to Antibiotics
• Chapter 12 Navigating the Pharmaceutical Boom: 1970s–1980s
• Chapter 13 Strategic Partnerships and Diversification
• Chapter 14 Leadership in the Modern Era: Visionaries and Their Impact
• Chapter 15 The Medco Acquisition: Entering Pharmacy Benefit Management
• Chapter 16 Entering the New Millennium: Challenges and Change
• Chapter 17 Oncology and the Keytruda Success Story
• Chapter 18 Gardasil and the Evolution of Vaccine Innovation
• Chapter 19 The Animal Health Division: Beyond Human Medicine
• Chapter 20 Research and Development in a Globalized World
• Chapter 21 Acquisitions and Strategic Growth in the 21st Century
• Chapter 22 Legal Controversies: The Vioxx Saga and Beyond
• Chapter 23 Corporate Social Responsibility and Philanthropy
• Chapter 24 The Organization Today: Leadership, Culture, and Global Reach
• Chapter 25 Future Prospects: Merck & Co. in the 21st Century and Beyond

Merck & Co., Inc. stands as one of the most formidable and influential pharmaceutical companies in the world. Its journey from modest beginnings as an extension of a centuries-old German apothecary to its current position atop the ranks of American and global industry is a narrative intertwined with scientific innovation, ethical challenges, and relentless ambition. The story of Merck & Co. is not merely one of corporate growth—it is a reflection of evolving priorities in medicine, science, and society as a whole.

Founded in 1891 as an offshoot of the Merck Group of Darmstadt, Germany, Merck & Co. became a distinctly American company under dramatic circumstances shaped by World War I. From this tumultuous separation, the company not only survived but thrived, rapidly building a reputation for scientific rigor and a passionate commitment to research and development. The decades that followed saw Merck at the forefront of medical breakthroughs—from the development of cortisone and antibiotics that reshaped the management of infectious and inflammatory diseases, to the invention and mass production of life-saving vaccines that changed public health across the globe.

The twentieth and early twenty-first centuries have brought both spectacular achievement and sobering controversy for Merck & Co. Its scientific contributions—from lowering cholesterol to battling cancer—have saved millions of lives. At the same time, legal and ethical challenges, exemplified most vividly by the Vioxx scandal, have forced the company to reevaluate its practices and priorities, altering the way it engages with doctors, regulators, and patients worldwide.

As the pharmaceutical industry has grown more competitive and complex, Merck has responded by deepening its focus on innovation, global expansion, and strategic partnerships. The company's commitment to research is evident in its continued investment in cutting-edge therapies, particularly in oncology and vaccines. Acquisitions of promising biotechnology firms and the vigorous pursuit of novel medicines demonstrate Merck’s resolve to remain at the leading edge of medical discovery.

Yet, the Merck story is also about responsibility: to patients, to scientific integrity, and to society. Its history of philanthropy and efforts to address global health challenges such as antimicrobial resistance show an awareness of the broader obligations it carries as a steward of life-saving treatments. With operations spanning continents and thousands of employees committed to a shared mission, Merck’s journey is a microcosm of the broader evolution of American enterprise and innovation.

This book chronicles over a century of progress, hurdles, transformations, and vision at Merck & Co. By exploring the company’s pioneering spirit, its triumphs and setbacks, and its growing role in global health, we aim to provide readers with a deep and nuanced understanding of what it means to build—and sustain—a great American company in the ever-shifting world of science and commerce.

The story of Merck & Co., while distinctly American in its modern form, begins centuries ago in a quaint pharmacy nestled in the heart of Darmstadt, Germany. This deep European lineage provides a crucial backdrop to understanding the company's enduring commitment to scientific rigor and its evolution into a global pharmaceutical powerhouse. It all started in 1668, a year that would mark the humble beginnings of what would become the world's oldest pharmaceutical and chemical company.

In that year, Friedrich Jacob Merck, a pharmacist who had previously owned a pharmacy in Wesselburen and managed the court pharmacy in Danzig, acquired the "Engel-Apotheke," or Angel Pharmacy, in Darmstadt. This acquisition laid the foundational stone for the Merck Group, a family enterprise that would, over generations, transform from a local apothecary into a sophisticated drug manufacturer. The Angel Pharmacy remains under the ownership of the Merck family to this day, a tangible link to its ancient origins.

For many decades, the Angel Pharmacy operated much like any other of its time, preparing remedies from plant, mineral, and animal sources. The pharmaceutical craft was then more empirical art than precise science, with formulations often lacking uniformity. However, the seeds of a more research-driven approach were implicitly present in the family's dedication to the apothecary trade.

Fast forward to 1827, a pivotal year that saw the Merck Group undergo a significant transformation. Five generations after Friedrich Jacob Merck's initial purchase, Heinrich Emanuel Merck, a descendant of Friedrich Jacob Merck's cousin, took the helm and steered the family business beyond the confines of a traditional pharmacy. He embarked on the commercial manufacture of morphine, a revolutionary step that signaled the company's shift towards industrial production.

This move was nothing short of groundbreaking. Morphine, first isolated in 1804 by German pharmacist Friedrich Wilhelm Sertürner, was the first medicinal alkaloid to be extracted from a plant, specifically the opium poppy. Merck’s large-scale production of morphine in 1827 marked a significant milestone, effectively ushering in the era of modern drug manufacturing. This innovation also established a new paradigm where pharmacists became patent-holders of the products they sold, dramatically expanding profitability and paving the way for the modern pharmaceutical industry.

Emanuel Merck’s foresight wasn’t limited to morphine. The company also went on to commercialize other important alkaloids, including codeine in 1836, and later, cocaine. This period of expansion saw Merck establishing business relationships across Europe and, by the mid-19th century, venturing into global markets, reaching Asia by 1832, North America by 1845, South America by 1851, Africa by 1867, and finally Australia by 1879.

The transformation from a small pharmacy to an industrial enterprise was a testament to the Merck family's enduring entrepreneurial spirit and their growing commitment to scientific inquiry. Emanuel Merck, with his sons, established E. Merck as a partnership, fostering an environment of shared responsibility and continuous growth. This collaborative approach, combined with a rapidly expanding product range, allowed the company to significantly increase its workforce and its global footprint.

By the late 19th century, the Merck Group had solidified its reputation as a leading chemical and pharmaceutical manufacturer. It was operating internationally, a true testament to its ambition. This robust German foundation, built on centuries of pharmaceutical tradition and decades of pioneering industrial chemistry, set the stage for the next critical chapter in the Merck story – its expansion across the Atlantic. The narrative of Merck & Co. truly begins with this rich German heritage, a story of an apothecary’s dream that blossomed into a global scientific endeavor.